Healthcare Disparities
The disparities may mean delays in diagnosis, which can lead to worse outcomes.
Saying no to recommended treatments for breast cancer may shorten a person’s life. Why are some groups of people more likely to decline breast cancer treatment?
After chemotherapy before surgery for triple-negative breast cancer, Black women are less likely and Hispanic women are more likely than white women to have a pathologic complete response.
Living in a neighborhood with few resources has been linked to worse breast cancer survival.
A tumor’s genetics — which varies by race — affects how a breast cancer responds to neoadjuvant chemotherapy and may contribute to differences in outcomes between Black and white women.
Black women at high risk of developing breast cancer face a number of barriers to risk-reducing care.
Breast cancer characteristics and environment equally contribute to worse breast cancer survival rates among Black women.
Black people diagnosed with breast or prostate cancer were less likely to receive radiation on a shorter, or hypofractionated, schedule.
LGBTQ people with breast cancer face delays in diagnosis and have a three times higher risk of recurrence than heterosexual cisgender people.
Among people with Medicare, Black women had less access to newer mammogram technology than white women.
Women from various racial and ethnic backgrounds, particularly Black women, had a higher risk of biopsy delays after an abnormal mammogram than white women.
Many Black people diagnosed with metastatic breast cancer never find out about clinical trials from their doctors even though most of them are open to participating in one.
Black, Hispanic, American Indian, and Alaskan Native people are vastly underrepresented in research studies on breast, prostate, lung, and colorectal cancer.
Women of color and women living in rural areas were more likely to miss regular screening mammograms during the COVID-19 pandemic than white and urban women.
A large percentage of the difference in breast cancer stage at diagnosis between white women and women of other ethnicities seems to be affected by whether a woman has insurance.